All for Joomla All for Webmasters

Day: March 29, 2017

St. Louis-Based Precision Virologics Receives $500,000 Investment in Biologically Targeted Vaccines for Zika and Chikungunya

St. Louis, MO (March 29, 2017) – Precision Virologics today announced a $500,000 investment from Oncolys BioPharma, a publicly traded Japanese company focusing on the development of novel viral-based biologics for the treatment of cancer and serious infectious diseases. This investment signals global interest in the St. Louis-based Precision, which is developing biologically targeted vaccines […]

Read More